BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

Japan Approves Sephience For All Ages Marking First PTC Product Clearance In The Country

– Indication includes all ages and the full spectrum of disease severity –– First Japan product approval for PTC – PTC T...

December 30, 2025 | News

Abbott Secures FDA Approval For Volt PFA System, Advancing Atrial Fibrillation Treatment In The United States

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm d...

December 29, 2025 | News

Galaxy Therapeutics Completes Enrollment In Landmark U.S. IDE Trial For Brain Aneurysm Device

Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, announced it has successfully completed e...

December 26, 2025 | News

HKSH Medical Group And Shenzhen Cancer Hospital Formalise Proton Therapy Collaboration Under Healthy China 2030 Framework

In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH")...

December 25, 2025 | News

Solventum Completes Acquisition Of Acera Surgical To Strengthen MedSurg And Wound Care Portfolio

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's bu...

December 24, 2025 | News

Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...

December 23, 2025 | News

Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer

Incyte Biosciences Japan G.K. announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination w...

December 23, 2025 | News

Alphamab Oncology’s JSKN003 Gains FDA Breakthrough Therapy Designation For Platinum Resistant Ovarian Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...

December 23, 2025 | News

Qihan Biotech Initiates Phase I IIa Dosing Of Allogeneic CAR T Therapy For Refractory Lupus

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-...

December 22, 2025 | News

Soin Neuroscience And BIOTRONIK Neuro Advance Personalised Spinal Cord Stimulation Research

Soin Neuroscience and BIOTRONIK Neuro announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscien...

December 22, 2025 | News

MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy

MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...

December 19, 2025 | News

Colour CT Breakthrough Reaches Europe As Charles University Adopts Advanced MARS Scanner

MARS Bioimaging, a New Zealand–headquartered medical device company specialising in spectral molecular imaging CT scanners that deliver colour 3D X-r...

December 19, 2025 | News

UK Hospitals Adopt AI Tool MEMORI To Strengthen Early Detection Of Hospital Acquired Infections

Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs...

December 18, 2025 | News

ALZpath Licenses pTau217 Antibody To Siemens Healthineers To Expand Blood Based Alzheimer’s Diagnostics

ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease and related dementias, announced a licensing ag...

December 17, 2025 | News

Stay Connected